Skip to main content

CMHCC 2025 Agenda

Omni King Edward Hotel, Toronto, ON

Friday, November 7th, 2025

Presentations include a 5-minute Q&A period.

7:00 – 8:00 Breakfast – Lobby Lounge / Sovereign Ballroom
8:00 – 8:10 Welcome to CMHCC – Sovereign Ballroom Chair: Dr. Laura Dawson
8:10- 9:00 Keynote: Systemic Treatment of Hepatocellular Carcinoma – Role in Advanced Stage and Potential in Earlier Stages Speaker: Dr. Peter Galle (GER)
9:00 – 10:35 Advanced Metastatic Hepatobiliary Sessions
Chairs: Dr. Brandon Meyers (ON) & Dr. Rachel Goodwin (ON)
9:00 – 9:25 Molecular Targets in BTC Speaker: Dr. Dom Bossé (ON)
9:25 – 9:45 Patient Selection in 1st Line Immune Therapy for HCC Speaker: Dr. Erica Tsang (ON)
9:45 – 10:05 Hepatitis B & C Management – Back to Basics Speaker: Dr. David Wong (ON)
10:05 – 10:35 Panels Discussion on Advanced Metastatic Hepatobiliary Sessions: Focus on IO Toxicity
Case 1: Hepatitis Post Immune Therapy
Case 2: Encephalitis Post IO
Panel Chairs: Dr. Brandon Meyers (ON) & Dr. Rachel Goodwin (ON)
Panelists: Dr. David Wong (ON), Dr. Erica Tsang (ON), Dr. Dom Bossé (ON), Dr. Peter Galle (GER)
10:35 – 10:55 Refreshment Break – Lobby Lounge
10:55 – 11:15 State of the Art Imaging for HCC (Diagnosis and Characterization and Updates in LIRADs Diagnosis and Response Assessment) Speaker: Dr. Mishal Mendiratta-Lala (MI)
11:15- 14:10 Intermediate/ Locally Advanced Hepatobiliary Session Chairs: Dr. Laura Dawson (ON) & Dr. Vincent Tam (AB)
11:20 – 11:40 Updates in SBRT for HCC, With Focus on MVI Speaker: Dr. Laura Dawson (ON)
11:40 – 12:00 TACE and TARE in HCC w MVI Speaker: Dr. Sabarinath Nair (ON)
12:00 – 12:20 Systemic Treatment for HCC with Vascular Invasion Speaker: Dr. Vincent Tam (AB)
12:20 – 12:40 Sequencing of IO and LRT Speaker: Dr. Howard Lim (BC)
12:40 – 13:40 Lunch – Lobby Lounge / Sovereign Ballroom
13:40 – 14:10 Panel Intermediate/ Locally Advanced Hepatobiliary Session Panel Chairs: Dr. Laura Dawson (ON) & Dr. Vincent Tam (AB)
Panelists: Dr. Howard Lim (BC), Dr. Mishal Mendiratta-Lala (MI), Dr. Sabarinath Nair (ON)
14:10 – 16:25 Early/Resectable Hepatobiliary Disease Sessions Chair: Dr. Maja Segedi (BC) & Dr. Pablo Serrano (ON)
14:15 – 14:35 Surgical Management of Early HCC and Intrahepatic Cholangiocarcinoma Speaker: Dr. Prosanto Chaudhury (QC)
14:35- 14:55 Expanding Indications for Transplant for HCC Speaker: Dr. Dr. Chaya Shwaartz (ON)
14:55 – 15:15 Updates in Ablative Techniques for HCC (Including Risks and Most Appropriate Patients for RFA, Microwave, and Even Histotripsy) Speaker: Dr. Mishal Mendiratta-Lala (MI)
15:15- 15:35 The Role of Radiation Therapy in Early-Stage HCC and Intrahepatic Cholangiocarcinoma Speaker: Dr. Emma Dunne (BC)
15:35- 15:55 Refreshment Break – Lobby Lounge
15:55 – 16:25 Early/Resectable Hepatobiliary Disease Panel Session Panel Chair: Dr. Maja Segedi (BC) & Dr. Pablo Serrano (ON)
Panelists: Dr. Emma Dunne (BC), Dr. Prosanto Chaudhury (QC), Dr. Mishal Mendiratta-Lala (MI), Dr. Chaya Shwaartz (ON)
16:25 – 16:30 Closing Remarks
16:30 – 17:30 CMHCC Closing Reception – Lobby Lounge